Registry for hereditary spastic paraplegia (HSP)
Part of Brain & nervous system, Genetic & congenital clinical trials.
This registry collects information from people with hereditary spastic paraplegia or spastic ataxia to help plan future treatments. It aims to better understand the condition and connect patients with potential therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of pure or complex hereditary spastic paraplegia (HSP) or spastic ataxia, even if the genetic cause isn't known yet.
- You or your legal guardian can provide informed consent to join the registry and allow data use.
- Your symptoms are not caused by another medical condition that mimics HSP.
- You don't have other major health issues that would change the main picture of your HSP (as decided by the doctor).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial aims to build a research network and gather information from people with two genetic types of hereditary spastic paraplegia (SPG4 and SPG5A). It will help doctors better understand these conditions and improve care.
This study looks at the causes and biology (“biomarkers”) of hereditary spastic paraplegias and related conditions. You may join as someone with the condition, a family member without symptoms, or a healthy person, to help researchers understand what’s happening in the nervous system.
This study follows people with hereditary spastic paraplegia that started in childhood to better understand how the condition progresses over time. It may help doctors learn what to expect and how to plan care, using genetic information and family history.
This trial tests if robot-assisted walking therapy can help people with hereditary spastic paraplegia (a condition causing progressive leg stiffness and weakness) improve their walking ability. It may be an option if you can walk indoors on your own.
This trial tests if a treatment called ITB (intrathecal baclofen) can help reduce muscle stiffness in people with hereditary spastic paraplegia (HSP). Participants will receive the treatment and be followed over time to see how well it works.
This study looks at people in families with a known SPG4 gene change (a SPAST mutation) to understand early, subtle signs and the beginning of symptoms. It may help researchers find better ways to detect SPG4 earlier, before full walking problems start.
Hear when a new Hereditary Spastic Paraplegia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.